Stefan Polei

Dr. Stefan Polei


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ASAnke Schmidt
Anke Schmidt
TWThomas von Woedtke
Thomas von Woedtke
JSJan Stenzel
Jan Stenzel
TLTobias Lindner
Tobias Lindner
SPStefan Polei
Stefan Polei
Sander BekeschusSander Bekeschus
Sander Bekeschus
Multiple evidence in animal models and in humans suggest a beneficial role of cold physical plasma in wound treatment. Yet, risk assessment studies are important to further foster therapeutic advancement and acceptance of cold plasma in clinics. Accordingly, we investigated the longterm side effects of repetitive plasma treatment over 14 consecutive days in a rodent full-thickness ear wound model. Subsequently, animals were housed for 350 days and sacrificed thereafter. In blood, systemic changes of the proinflammatory cytokines interleukin 1β and tumor necrosis factor α were absent. Similarly, tumor marker levels of α-fetoprotein and calcitonin remained unchanged. Using quantitative PCR, the expression levels of several cytokines and tumor markers in liver, lung, and skin were found to be similar in the control and treatment group as well. Likewise, histological and immunohistochemical analysis failed to detect abnormal morphological changes and the presence of tumor markers such as carcinoembryonic antigen, α-fetoprotein, or the neighbor of Punc 11. Absence of neoplastic lesions was confirmed by non-invasive imaging methods such as anatomical magnetic resonance imaging and positron emission tomography-computed tomography. Our results suggest that the beneficial effects of cold plasma in wound healing come without apparent side effects including tumor formation or chronic inflammation.

4 March 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
ASAnne Strübing
Anne Strübing
EAEstelle Akl
Estelle Akl
CLChris Lappe
Chris Lappe
SPStefan Polei
Stefan Polei
OSOliver Stachs
Oliver Stachs
EBEbba Beller
Ebba Beller
Background: Radiomic analyses have been extensively explored in oncologic imaging and more recently in neuroimaging. However, radiomic characterization of the crystalline lens using computed tomography has not yet been systematically investigated. Methods: In this retrospective study, semiautomatic segmentation of the eye lens on orbital CT was performed on 112 patients (mean age 48 ± 20 years, 38% female). After radiomics feature extraction, a Boruta feature selection approach based on the random forest algorithm was applied to select the most relevant radiomics features. Severity of white matter lesions were graded according to the Fazekas scale for each patient on axial non-contrast head CT. Results: In total, 17 important features were associated with age-related changes in the eye lens and three important radiomic features for the differentiation between patients with a Fazekas score > 1 and a control group. Significantly higher values were found in patients with a Fazekas score > 1 compared to the control group regarding all three features, “ClusterShade”, “Skewness” and “DifferenceVariance” (p = 0.0006, 0.0023 and 0.0376, respectively), which are all measures of heterogeneity. No important radiomic features of the eye lens were confirmed between patients with and without hypertension. Conclusions: To the best of our knowledge, this is the first study to use CT-based radiomic analysis of the crystalline lens to detect differences among demographic or clinical groups with small vessel disease. The present results might help to expand the range of applications of radiomics regarding ophthalmic (patho-)physiology and suggest a possible new biomarker for systemic vascular diseases.